These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34386102)

  • 1. Cationic oligonucleotide derivatives and conjugates: A favorable approach for enhanced DNA and RNA targeting oligonucleotides.
    Danielsen MB; Wengel J
    Beilstein J Org Chem; 2021; 17():1828-1848. PubMed ID: 34386102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.
    Yoshida T; Morihiro K; Naito Y; Mikami A; Kasahara Y; Inoue T; Obika S
    Nucleic Acids Res; 2022 Jul; 50(13):7224-7234. PubMed ID: 35801870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides.
    Deglane G; Abes S; Michel T; Prévot P; Vives E; Debart F; Barvik I; Lebleu B; Vasseur JJ
    Chembiochem; 2006 Apr; 7(4):684-92. PubMed ID: 16518865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Properties of Nucleobase-Sugar Dual Modified Nucleic Acids: 2
    Sakurai Y; Yamaguchi T; Yoshida T; Horiba M; Inoue T; Obika S
    J Org Chem; 2023 Jan; 88(1):154-162. PubMed ID: 36520114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of sugar-modified oligonucleotides for antisense therapeutics.
    Prakash TP
    Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
    Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
    Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides.
    Bailey JK; Shen W; Liang XH; Crooke ST
    Nucleic Acids Res; 2017 Oct; 45(18):10649-10671. PubMed ID: 28977508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.
    Hvam ML; Cai Y; Dagnæs-Hansen F; Nielsen JS; Wengel J; Kjems J; Howard KA
    Mol Ther; 2017 Jul; 25(7):1710-1717. PubMed ID: 28641935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide.
    Tanaka K; Okuda T; Kasahara Y; Obika S
    Mol Ther Nucleic Acids; 2021 Mar; 23():440-449. PubMed ID: 33473329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.
    Hegarty JP; Krzeminski J; Sharma AK; Guzman-Villanueva D; Weissig V; Stewart DB
    Int J Nanomedicine; 2016; 11():3607-19. PubMed ID: 27536102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in non-native nucleic acid modifications.
    McKenzie LK; El-Khoury R; Thorpe JD; Damha MJ; Hollenstein M
    Chem Soc Rev; 2021 Apr; 50(8):5126-5164. PubMed ID: 33644787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA.
    Pendergraff HM; Krishnamurthy PM; Debacker AJ; Moazami MP; Sharma VK; Niitsoo L; Yu Y; Tan YN; Haitchi HM; Watts JK
    Mol Ther Nucleic Acids; 2017 Sep; 8():158-168. PubMed ID: 28918018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases.
    Helm J; Schöls L; Hauser S
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications.
    Kojima N; Shrestha AR; Akisawa T; Piao H; Kizawa H; Ohmiya Y; Kurita R
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):258-269. PubMed ID: 31556356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences.
    Yoshida T; Naito Y; Sasaki K; Uchida E; Sato Y; Naito M; Kawanishi T; Obika S; Inoue T
    Genes Cells; 2018 Jun; 23(6):448-455. PubMed ID: 29667281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells.
    Wang S; Allen N; Prakash TP; Liang XH; Crooke ST
    Nucleic Acid Ther; 2019 Oct; 29(5):245-255. PubMed ID: 31158063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond.
    Jiang R; Hooshfar S; Rebecca Eno M; Yun C; Sonego Zimmermann E; Shinkyo R
    Curr Drug Metab; 2023; 24(7):536-552. PubMed ID: 37076460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications.
    Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M
    Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics.
    Cai Y; Lou C; Wengel J; Howard KA
    Methods Mol Biol; 2020; 2176():163-174. PubMed ID: 32865790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.
    Swayze EE; Siwkowski AM; Wancewicz EV; Migawa MT; Wyrzykiewicz TK; Hung G; Monia BP; Bennett CF
    Nucleic Acids Res; 2007; 35(2):687-700. PubMed ID: 17182632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.